Inhibition of Herpes Simplex Viruses, Types 1 and 2, by Ginsenoside 20(S)-Rg3

Infections by herpes simplex viruses have an immense impact on humans, ranging from selflimiting, benign illness to serious, life-threatening diseases. While nucleoside analog drugs are available, resistance has been increasing and currently no vaccine exists. Ginsenosides derived from Panax ginseng...

Descripción completa

Detalles Bibliográficos
Autores principales: Wright, Stephen M., Altman, Elliot
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Korean Society for Microbiology and Biotechnology 2020
Materias:
Research article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9728284/
https://www.ncbi.nlm.nih.gov/pubmed/31693840
http://dx.doi.org/10.4014/jmb.1908.08047

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9728284/
https://www.ncbi.nlm.nih.gov/pubmed/31693840
http://dx.doi.org/10.4014/jmb.1908.08047

Ejemplares similares